The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
MicroRNA signature to predict sensitivity to anti-EGFR monoclonal antibodies in metastatic colorectal cancer (mCRC).
Federico Cappuzzo
No relevant relationships to disclose
Andrea Sacconi
No relevant relationships to disclose
Lorenza Landi
No relevant relationships to disclose
Francesca Biagioni
No relevant relationships to disclose
Vienna Ludovini
No relevant relationships to disclose
Gabriella Fontanini
No relevant relationships to disclose
Elisa Sensi
No relevant relationships to disclose
Cristiana Lupi
No relevant relationships to disclose
Jessica Salvini
No relevant relationships to disclose
Giovanni Blandino
No relevant relationships to disclose
Lucio Crinò
No relevant relationships to disclose